E2511

DRUG3 trials

Sponsors

Eisai Inc.

Conditions

Alzheimers DiseaseHealthy Volunteers

Phase 1

A Study to Assess the Safety and Tolerability of E2511 in Healthy Participants

CompletedNCT04547361

Eisai Inc.Healthy Volunteers

Start: 2020-09-14End: 2021-05-26Updated: 2021-07-12

A Study to Assess the Safety and Tolerability of E2511 in Healthy Adult and Elderly Participants

CompletedNCT05147337

Eisai Inc.Healthy Volunteers

Start: 2021-12-01End: 2022-08-18Updated: 2022-09-09

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2511 in Participants With Early Alzheimer's Disease (AD)

Not yet recruitingNCT07768592

Eisai Inc.Alzheimers Disease

Start: 2026-10-15End: 2030-05-06Target: 32Updated: 2026-08-17